Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25267501 | 0.79 | CSNK1E (0.36) | CSNK1ECSNK1D | |
| SCHEMBL26645617 | 0.77 | CSNK1D (0.30) | CSNK1ECSNK1D | |
| SCHEMBL24415147 | 0.72 | CSNK1E (0.34) | CSNK1ECSNK1D | |
| SCHEMBL30515595 | 0.71 | GABRA1 (0.35) | CSNK1ECSNK1D | |
| SCHEMBL28919359 | 0.70 | DPP4 (0.32) | — | |
| SCHEMBL30622755 | 0.70 | GRM5 (0.39) | CSNK1ECSNK1D | |
| SCHEMBL26645074 | 0.70 | CSNK1E (0.42) | CSNK1ECSNK1D | |
| SCHEMBL22412787 | 0.69 | GRM5 (0.35) | — | |
| SCHEMBL26645063 | 0.67 | NR1H2 (0.38) | — | |
| SCHEMBL26969083 | 0.66 | ALDH1A1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059188-A1 | ARYLSULPHONAMIDE COMPOUNDS | Anaxis Pharma Pty Ltd (AU) | 2025-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059188-A1 | ARYLSULPHONAMIDE COMPOUNDS | MLKL, CASP1, CASP9 | CSNK1E 203/4885CSNK1D 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.